Granisetron Hydrochloride Patent Expiration

Granisetron Hydrochloride is Used for managing post-operative nausea and vomiting. It was first introduced by Hoffmann La Roche Inc in its drug Kytril on Dec 29, 1993. 29 different companies have introduced drugs containing Granisetron Hydrochloride.


Granisetron Hydrochloride Patents

Given below is the list of patents protecting Granisetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Kytril US5952340 Use of granisetron for the treatment of postoperative nausea and vomiting Sep 14, 2016

(Expired)

Roche



Granisetron Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Granisetron Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Granisetron Hydrochloride. The first generic version for Granisetron Hydrochloride was by Amneal Eu Ltd and was approved on Dec 31, 2007. And the latest generic version is by Intra-Sana Laboratories Llc and was approved on Mar 17, 2025.

Given below is the list of companies who have filed for Granisetron Hydrochloride generic, along with the locations of their manufacturing plants worldwide.